Cantor: Time To Buy StemCells

By: via Benzinga
In a report published Friday, Cantor Fitzgerald analysts initiated coverage of StemCells Inc (NASDAQ: STEM) with a Buy rating and a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.